Immunotherapy in Ovarian Cancer
Recent trials in Ovarian Cancer and Immunotherapy
Ovarian Cancer
DESTINY-PanTumor02
Phase II study evaluating the role of HER2-directed ADC Trastuzumab deruxtecan (T-DxD)
Surgical technique for Risk Reduction Salpingo-oophorectomy
Do you perform RRSO? What is your technique
Venous Thromboembolism Prevention in Ovarian Cancer
VTE prophylaxis from the start of NACT to the end of treatment can reduce VTE rates by 80%